MARKET

NMTR

NMTR

9 Meters Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7698
+0.0057
+0.75%
After Hours: 0.7698 0 0.00% 16:58 10/23 EDT
OPEN
0.7900
PREV CLOSE
0.7641
HIGH
0.7900
LOW
0.7500
VOLUME
612.37K
TURNOVER
--
52 WEEK HIGH
1.220
52 WEEK LOW
0.3701
MARKET CAP
109.49M
P/E (TTM)
-0.6644
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Mixed shelf roundup - healthcare
The following healthcare companies have filed for mixed shelf offerings:Agile Therapeutics (AGRX): $200M.9 Meters Biopharma (NMTR): $200M.Sintx Technologies (SINT): $75M.
Seekingalpha · 10/05 08:37
9 Meters Biopharma Announces It Files For A Mixed Shelf Offering Of Upto $200M
-Reuters
Reuters · 10/02 20:16
Tiny 9 Meters Bio moving after William Blair coverage spots big opportunity
William Blair initiates coverage on $95M market cap 9 Meters Biotech (NMTR), saying its pipeline is a "blockbuster in the making."The current Phase 3 study of larazotide should show results
Seekingalpha · 09/23 11:40
Insider Buys 9 Meters Biopharma Shares
9 Meters Biopharma Inc (NASDAQ:NMTR) was trading 8.4% higher from the previous closing price.
Benzinga · 09/14 15:55
9 Meters Biopharma, Inc. Announces Formation Of Scientific Advisory Board
RALEIGH, NC / ACCESSWIRE / August 31, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the formation of its scientific advisory board
Benzinga · 08/31 12:31
Insider Buys 9 Meters Biopharma's Shares
A Form 4 filing filed with the SEC on Monday, August 24 showed that Temperato John bought 70,000 shares of 9 Meters Biopharma Inc (NASDAQ:NMTR) at an average price of $0.69. The transaction moved the executive's stake in 9 Meters Biopharma Inc. to 615,496
Benzinga · 08/24 15:53
GRWG, MNTA, BMRN and VIPS among midday movers
Gainers: Allied Esports Entertainment (AESE) +94%.Momenta Pharmaceuticals (MNTA) +69%.Hudson (HUD) +46%.9 Meters Biopharma (NMTR) +43%.Kirkland's (KIRK) +26%.Innodata (INOD) +21%.VivoPower International (VVPR) +19%.Wah Fu Education (WAFU) +18%.AutoWeb (AUTO) +18%.GrowGeneration (GRWG) +17%.Losers: BioMarin Pharmaceutical (BMRN) -35%.Galapagos (GLPG) -25%.Greenpro
Seekingalpha · 08/19 16:43
9 Meters Biopharm +35% as director buys shares
9 Meters Biopharma (NMTR) is up 35% pre-market consecutively, as company discloses Director Sirgo Mark A bought 100k shares at $0.56/share, on August 17, 2020.Mark now owns 411784 shares.Previously: 9 Meters Biopharma soars
Seekingalpha · 08/19 13:07
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NMTR. Analyze the recent business situations of 9 Meters Biopharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NMTR stock price target is 4.333 with a high estimate of 5.00 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 35
Institutional Holdings: 28.65M
% Owned: 20.15%
Shares Outstanding: 142.23M
TypeInstitutionsShares
Increased
6
54.40K
New
20
27.08M
Decreased
4
195.66K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.56%
Pharmaceuticals & Medical Research
+0.69%
Key Executives
Chairman/Chief Executive Officer/Director
Sandeep Laumas
Chief Financial Officer/Chief Accounting Officer
Edward Sitar
Other
Patrick Griffin
Director
Michael Constantino
Director
John Temperato
Vice President - Operations
Marc Matejka
Independent Director
Nissim Darvish
Independent Director
Lorin Johnson
Independent Director
Roy Proujansky
Independent Director
Mark Sirgo
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NMTR
9 Meters Biopharma, Inc., formerly Innovate Biopharmaceuticals, Inc., is a gastrointestinal platform company. The Company is focused on developing treatments for patients with rare disorders and unmet needs. Its pipeline includes drug candidates for short bowel syndrome and celiac disease. Its pipeline includes NM-002, Larazotide, NM-003 and NM-004. NM-002 is a long-acting injectable GLP-1 analogue for short bowel syndrome (SBS). Larazotide is an orally administered, gut-restricted tight-junction regulator for celiac disease. NM-003 is a GLP-2 analogue, under orphan indication selection. NM -004 is an immunomodulator, granted pediatric orphan designation in ulcerative colitis.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of 9 Meters Biopharma Inc stock information, including NASDAQ:NMTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMTR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NMTR stock methods without spending real money on the virtual paper trading platform.